Spatiotemporal transcriptomics elucidates the pathogenesis of fulminant viral myocarditis

Huihui Li1, Xueting Chen2,3, James Jiqi Wang1

  • 1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, China.

Insights

Fulminant myocarditis (FM) involves mesothelial cells and immune cells like macrophages and T cells. Targeting the IFN-γ/Spi1 pathway with treatments like IVIG shows promise for managing this severe heart condition.

Area of Science:

  • Cardiology
  • Immunology
  • Virology

Background:

  • Fulminant myocarditis (FM) is a severe, often fatal, myocardial inflammation.
  • Coxsackievirus B3 (CVB3) is a common cause of viral myocarditis.

Purpose of the Study:

  • To elucidate the spatiotemporal pathogenesis of CVB3-induced FM using transcriptomics.
  • To identify key cellular players and molecular pathways involved in FM.
  • To evaluate therapeutic strategies targeting identified pathways.

Main Methods:

  • Single-nucleus and spatial transcriptomics in a mouse model of CVB3-induced FM.
  • Analysis across seven time points pre- and post-treatment.
  • Assessment of therapeutic interventions, including IVIG.

Main Results:

  • Mesothelial cells are early targets of CVB3, initiating macrophage activation and inflammation.
  • Cd8+ effector T cells and IFN-γ contribute to cardiomyocyte injury via the Spi1 pathway.
  • IFN-γ/Spi1 axis targeted therapies and IVIG showed significant efficacy in reducing mortality and inflammation.

Conclusions:

  • CVB3-induced FM involves a complex interplay of mesothelial cells, macrophages, and T cells.
  • The IFN-γ/Spi1 axis is a critical mediator of cardiac damage in FM.
  • IVIG demonstrates therapeutic potential by modulating viral load and hyperinflammation.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...